1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with phosphocreatine in 12 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (phosphocreatine) | Trials (phosphocreatine) | Recent Studies (post-2010) (phosphocreatine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 7,475 | 329 | 575 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, NG; Braquet, PG; Emoto, SE; Esanu, A; Fitzpatrick, JH; Gilboe, DD; Kintner, D | 1 |
| Kakishita, E; Nagai, K; Oura, Y; Suehiro, A | 1 |
| Grignani, G; Jamieson, GA | 1 |
| Cerletti, C; de Gaetano, G; Lauri, D | 1 |
| Korth, R; Mangold, HK; Muramatsu, T; Zöllner, N | 1 |
| Haslam, RJ; Vanderwel, M | 1 |
| Broekman, MJ; Kaplan, KL; Marcus, AJ; Safier, LB; Ullman, HL; Weksler, BB; Wong, KT | 1 |
| Hillmar, I; Korth, R; Muramatsu, T; Zöllner, N | 1 |
| Akkerman, JW; De Haas, GH; Gorter, G; Kloprogge, E | 1 |
| Byers, LW; Chesney, CM; Muirhead, EE; Pifer, DD | 1 |
| Benveniste, J; Fouque, F; Odiot, J; Vargaftig, BB | 1 |
| Jørgensen, L; Kinlough-Rathbone, RL; Mustard, JF; Nilsen, GJ; Perry, DW | 1 |
12 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and phosphocreatine
| Article | Year |
|---|---|
Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists.
Topics: Adenosine Monophosphate; Animals; Azepines; Brain; Creatine; Dimethyl Sulfoxide; Dogs; Electroencephalography; Evoked Potentials, Auditory; Free Radical Scavengers; Glucose; Glycogen; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Kinetics; Oxygen; Phosphocreatine; Platelet Activating Factor; Thienopyridines; Triazoles; Vascular Resistance | 1991 |
Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood.
Topics: Adenosine Diphosphate; Adult; Aspirin; Creatine Kinase; Drug Synergism; Humans; In Vitro Techniques; Male; Phosphocreatine; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Verapamil; Vitamin E | 1990 |
Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line.
Topics: Antibodies; Blood Platelets; Cell Line; Creatine Kinase; Hirudins; Humans; Inclusion Bodies; Lung Neoplasms; Osteosarcoma; Phosphocreatine; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Thromboplastin | 1987 |
Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.
Topics: Adenosine Diphosphate; Aspirin; Creatine Kinase; Drug Interactions; Humans; Kinetics; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation | 1986 |
Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines (unsaturated platelet-activating factor): aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release
Topics: Blood Platelets; Creatine Kinase; Female; Hirudins; Humans; Indomethacin; Lidocaine; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1985 |
Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Creatine Kinase; Cyclic AMP; Indomethacin; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Prostaglandins E; Rabbits | 1982 |
Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro.
Topics: Adenosine Diphosphate; Apyrase; beta-Thromboglobulin; Blood Platelets; Calcium; Creatine Kinase; Drug Synergism; Humans; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Serotonin; Thromboxane A2 | 1981 |
1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes.
Topics: Blood Platelets; Hirudins; Humans; Indomethacin; Kinetics; Lidocaine; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1983 |
Stimulus-response coupling in human platelets. Evidence against a role of PAF-acether in the "third pathway'.
Topics: Aspirin; Blood Platelets; Creatine Kinase; Humans; In Vitro Techniques; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Thrombin | 1983 |
Effect of platelet-activating factor (PAF) on human platelets.
Topics: Animals; Antimycin A; Aspirin; Blood Platelets; Cattle; Creatine Kinase; Deoxyglucose; Epoprostenol; Humans; Indomethacin; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Serotonin | 1982 |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Aspirin; Creatine Kinase; Drug Synergism; Epinephrine; Humans; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Rabbits; Stimulation, Chemical; Thromboxane B2 | 1982 |
Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Cell Communication; Cells, Cultured; Centrifugation, Density Gradient; Creatine Kinase; Edetic Acid; Ferric Compounds; Macrophages, Alveolar; Microscopy, Electron; Phosphocreatine; Platelet Activating Factor; Platelet Activation; Rabbits; Thrombin; Triazolam | 1993 |